BiotechTube
Home/Biond Biologics/Ilana Mandel, Ph.D.
IM

Ilana Mandel, Ph.D.

Chief Scientific Officer

Biond Biologics

Therapeutic Areas

OncologyImmunology

Biond Biologics Pipeline

DrugIndicationPhase
BND-22 (SAR44481)Solid TumorsPhase 1/2
BND-35Solid TumorsPhase 1/2

Leadership Team at Biond Biologics

TB
Tehila Ben Moshe, Ph.D.
Co‑Founder, Chairperson & Chief Executive Officer
OS
Ori Shilo, MBA
Co‑Founder & Chief Financial Officer
YS
Yair Sapir, Ph.D., MBA
Chief Operations Officer
View full Biond Biologics profile